New Issue: Bank of America prices $2.5 million 9.7% autocallable yield notes linked to three stocks

By Susanna Moon

Chicago, Nov. 18 – Bank of America Corp. priced $2.5 million of 9.7% autocallable yield notes due Nov. 18, 2016 linked to worst performing of the common stocks of Celgene Corp., MetLife, Inc. and Merck & Co., Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable quarterly.

The notes will be called at par plus the coupon if each stock price closes at or above the initial price on any quarterly call observation date beginning Feb. 16, 2016.

The payout at maturity will be par unless any stock finishes below the 65% trigger level, in which case the payout will be par plus the return of the worst performing stock.

BofA Merrill Lynch is the agent.

Issuer:	Bank of America Corp.
Issue:	Autocallable yield notes
Underlying stocks:	Celgene Corp. (Symbol: CELG), MetLife, Inc. (Symbol: MET) and Merck & Co., Inc. (Symbol: MRK)
Amount:	$2.5 million
Maturity:	Nov. 18, 2016
Coupon:	9.7%, payable quarterly
Price:	Par
Payout at maturity:	Par unless any stock falls by more than 35%, in which case par plus return of worst performing stock, with full exposure to any losses
Call:	At par if stock closes at or above initial share price on any quarterly call date beginning Feb. 16, 2016
Initial levels:	$108.34 for Celgene, $49.88 for MetLife and $53.34 for Merck
Trigger levels:	65% of initial levels
Pricing date:	Nov. 13
Settlement date:	Nov. 18
Agent:	BofA Merrill Lynch
Fees:	0.5%
Cusip:	06048WSB7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.